RIL
ACHV icon

Rothschild Investment LLC’s Achieve Life Sciences ACHV Stock Holding History

Rothschild Investment LLC’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.83K Buy
+739
New +$3.52K ﹤0.01% 2287

Other funds holding ACHV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MF
Manchester Financial Westlake Village, California $563M AUM 21.72% 1-Year Est. Return
MW
Members Wealth Media, Pennsylvania $182M AUM 15.09% 1-Year Est. Return

Rothschild Investment LLC's ACHV Position: Q2 2026 in Review

Rothschild Investment LLC opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 739 shares worth $4.83K. The stake represents ﹤0.01% of the portfolio and ranks #2287 among its holdings.

28 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Rothschild Investment LLC held 739 shares of Achieve Life Sciences worth $4.83K as of Q2 2026.
  • Achieve Life Sciences was a new Rothschild Investment LLC position in Q2 2026.
  • Achieve Life Sciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2287 holding.
  • 28 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.